Inhaled corticosteroid (ICS)–based therapy is often used for patients with chronic obstructive
pulmonary disease (COPD). However, this approach is under scrutiny because of ICS …

To investigate the association between inhaled corticosteroid (ICS) exposure patterns and
the risk of pneumonia in chronic obstructive pulmonary disease (COPD) patients, we …

Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …

PURPOSE: Although inhaled corticosteroids are commonly used to treat patients with
chronic obstructive pulmonary disease (COPD), their effect on clinical outcomes such as …

COPD is a progressive disease where airway inflammation plays an important part.
Previously, there were large expectations that regular anti-inflammatory treatment with …

Chronic obstructive pulmonary disease (COPD) is an independent risk factor for
osteoporosis. Oral glucocorticoids are deleterious to bone; however, the impact of inhaled …

There is a considerable amount of evidence that supports the possibility of an increased risk
of pneumonia associated with prolonged use of inhaled corticosteroids (ICS) in patients with …

The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

The role of inhaled corticosteroids (ICS) in asthma is well established, but their benefit in the
management of chronic obstructive pulmonary disease (COPD) is still controversial. The …

Recent studies suggest that use of inhaled corticosteroids (ICS) in chronic obstructive
pulmonary disease (COPD) may be associated with a higher incidence of pneumonia …